2025
SJR Q1
JCR Q1 · 13,1
38 matched articles
SCIE
Journal detail
Neuro-Oncology
- Publisher
- Oxford University Press
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
1522851715235866
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 5,249
- Quartile Q1
- H-Index 189
- Cites/doc 9,63
- Docs (3y) 738
- Cites (3y) 7.168
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 13,1
- 5Y JIF 16,7
- JCI 2,79
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Cancer Research Q1
- Neurology (clinical) Q1
- Oncology Q1
WoS categories
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 5,249 | 13,1 | 16,7 | 2,79 | Q1 | 189 |
| 2024 | Q1 | Q1 | 6,974 | 13,4 | 16 | 3,45 | Q1 | 178 |
| 2023 | Q1 | Q1 | 6,348 | 16,4 | 14,9 | 3,38 | Q1 | 178 |
| 2022 | Q1 | Q1 | 4,833 | 15,9 | 15,1 | 3,22 | Q1 | 178 |
| 2021 | Q1 | Q1 | 3,097 | 13 | 14,1 | 2,38 | Q1 | 178 |
| 2020 | Q1 | Q1 | 4,005 | 12,3 | 13 | 2,49 | Q1 | 178 |
| 2019 | Q1 | Q1 | 4,241 | 10,2 | 9,6 | 2,59 | Q1 | 178 |
| 2018 | — | Q1 | — | 10,1 | 9,1 | 2,55 | Q1 | — |
| 2017 | Q1 | Q1 | 4,064 | 9,4 | 8,7 | 2,38 | Q1 | 178 |
| 2016 | Q1 | Q1 | 3,048 | 7,8 | 7,1 | — | — | 178 |
| 2015 | Q1 | Q1 | 3,246 | 7,4 | 7 | — | — | 178 |
| 2014 | Q1 | Q1 | 3,079 | 6,8 | 6,6 | — | — | 178 |
| 2013 | Q1 | Q1 | 2,98 | 5,3 | 5,7 | — | — | 178 |
| 2012 | Q1 | Q1 | 2,753 | 6,2 | 5,9 | — | — | 178 |
| 2011 | Q1 | Q1 | 2,587 | 5,7 | 5,9 | — | — | 178 |
| 2010 | Q1 | Q1 | 2,19 | 5,5 | 6 | — | — | 178 |
| 2009 | — | Q1 | — | 5 | 5,8 | — | — | — |
| 2008 | — | Q1 | — | 5 | 5,3 | — | — | — |
| 2007 | — | Q1 | — | 5,8 | 4,8 | — | — | — |
| 2006 | — | Q1 | — | 4,9 | — | — | — | — |
| 2005 | — | Q1 | — | 4,2 | — | — | — | — |
| 2004 | — | Q1 | — | 3,9 | — | — | — | — |
| 2003 | — | Q1 | — | 3,4 | — | — | — | — |
| 2002 | — | Q1 | — | 2,7 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | CLINICAL NEUROLOGY | SCIE | Q1 | Q1 | 4/296 |
| 2025 | ONCOLOGY | SCIE | Q1 | Q1 | 25/333 |
| 2024 | CLINICAL NEUROLOGY | SCIE | Q1 | Q1 | 4/286 |
| 2024 | ONCOLOGY | SCIE | Q1 | Q1 | 20/328 |
| 2023 | CLINICAL NEUROLOGY | SCIE | Q1 | Q1 | 4/280 |
| 2023 | ONCOLOGY | SCIE | Q1 | Q1 | 15/322 |
| 2022 | CLINICAL NEUROLOGY | SCIE | Q1 | Q1 | 4/212 |
| 2022 | ONCOLOGY | SCIE | Q1 | Q1 | 16/241 |
| 2021 | CLINICAL NEUROLOGY | SCIE | Q1 | Q1 | 8/212 |
| 2021 | ONCOLOGY | SCIE | Q1 | Q1 | 21/245 |
| 2020 | CLINICAL NEUROLOGY | SCIE | Q1 | Q1 | 7/208 |
| 2020 | ONCOLOGY | SCIE | Q1 | Q1 | 19/242 |
| 2019 | CLINICAL NEUROLOGY | SCIE | Q1 | Q1 | 7/204 |
| 2019 | ONCOLOGY | SCIE | Q1 | Q1 | 17/244 |
| 2018 | CLINICAL NEUROLOGY | SCIE | Q1 | Q1 | 8/199 |
| 2018 | ONCOLOGY | SCIE | Q1 | Q1 | 13/230 |
| 2017 | CLINICAL NEUROLOGY | SCIE | Q1 | Q1 | 9/197 |
| 2017 | ONCOLOGY | SCIE | Q1 | Q1 | 15/223 |
| 2016 | CLINICAL NEUROLOGY | SCIE | Q1 | — | 10/194 |
| 2016 | ONCOLOGY | SCIE | Q1 | — | 19/217 |
| 2015 | CLINICAL NEUROLOGY | SCIE | Q1 | — | 9/193 |
| 2015 | ONCOLOGY | SCIE | Q1 | — | 19/213 |
| 2014 | CLINICAL NEUROLOGY | SCIE | Q1 | — | 13/192 |
| 2014 | ONCOLOGY | SCIE | Q1 | — | 19/211 |
| 2013 | CLINICAL NEUROLOGY | SCIE | Q1 | — | 18/194 |
| 2013 | ONCOLOGY | SCIE | Q1 | — | 30/203 |
| 2012 | CLINICAL NEUROLOGY | SCIE | Q1 | — | 10/193 |
| 2012 | ONCOLOGY | SCIE | Q1 | — | 24/197 |
| 2011 | CLINICAL NEUROLOGY | SCIE | Q1 | — | 15/192 |
| 2011 | ONCOLOGY | SCIE | Q1 | — | 23/196 |
| 2010 | CLINICAL NEUROLOGY | SCIE | Q1 | — | 15/185 |
| 2010 | ONCOLOGY | SCIE | Q1 | — | 24/185 |
| 2009 | CLINICAL NEUROLOGY | SCIE | Q1 | — | 17/167 |
| 2009 | ONCOLOGY | SCIE | Q1 | — | 27/166 |
| 2008 | CLINICAL NEUROLOGY | SCIE | Q1 | — | 15/156 |
| 2008 | ONCOLOGY | SCIE | Q1 | — | 25/143 |
| 2007 | CLINICAL NEUROLOGY | SCIE | Q1 | — | 6/146 |
| 2007 | ONCOLOGY | SCIE | Q1 | — | 16/132 |
| 2006 | CLINICAL NEUROLOGY | SCIE | Q1 | — | 14/147 |
| 2006 | ONCOLOGY | SCIE | Q1 | — | 23/127 |
| 2005 | CLINICAL NEUROLOGY | SCIE | Q1 | — | 15/148 |
| 2005 | ONCOLOGY | SCIE | Q1 | — | 30/123 |
| 2004 | CLINICAL NEUROLOGY | SCIE | Q1 | — | 15/140 |
| 2004 | ONCOLOGY | SCIE | Q2 | — | 32/123 |
| 2003 | CLINICAL NEUROLOGY | SCIE | Q1 | — | 16/135 |
| 2003 | ONCOLOGY | SCIE | Q2 | — | 34/120 |
| 2002 | CLINICAL NEUROLOGY | SCIE | Q1 | — | 26/138 |
| 2002 | ONCOLOGY | SCIE | Q2 | — | 41/114 |